Matinas BioPharma Holdings, Inc. (MTNB) has 26 open-market insider trades by 10 insiders since 2017. The most active filer is Adam K. Stern, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Adam K. Stern | 10% Owner | — | 10 | $444K | 2026-07-10 |
| Patrick G. Lepore | Dir | — | 4 | $346K | 2020-05-14 |
| Herbert J. Conrad | Dir | — | 2 | $154K | 2022-06-22 |
| Keith A. Kucinski | CFO | — | 1 | $115K | 2019-11-25 |
| Eric J. Ende | Dir | — | 2 | $27K | 2021-06-19 |
| Jerome D. Jabbour | Pres | — | 3 | $26K | 2021-06-19 |
| Raphael J. Mannino | Chief Scientific Officer | — | 1 | $7K | 2021-09-03 |
| Roelof Rongen | CEO | — | 1 | $7K | 2017-09-08 |
| James S. Scibetta | Dir | — | 1 | $6K | 2021-06-19 |
| Stefano Ferrari | Dir | — | 1 | $6K | 2017-09-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Adam K. Stern | Director | Buy | $17K | 2020-08-21 |
| Patrick G. Lepore | Director | Buy | $73K | 2020-05-14 |
| Jerome D. Jabbour | President | Buy | $7K | 2020-03-17 |
| Keith A. Kucinski | CFO | Buy | $115K | 2019-11-22 |
| Patrick G. Lepore | Director | Buy | $106K | 2019-11-15 |
| Eric J. Ende | Director | Buy | $13K | 2019-08-20 |
Companies that share insiders with MTNB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Adam K. Stern | Director | Buy | $7K | 2019-08-19 |
| Jerome D. Jabbour | President | Buy | $10K | 2019-08-19 |
| Eric J. Ende | Director | Buy | $14K | 2019-08-19 |
| Patrick G. Lepore | Director | Buy | $72K | 2019-08-16 |
| Adam K. Stern | Director | Buy | $12K | 2019-06-14 |
| Adam K. Stern | Director | Buy | $16K | 2019-06-12 |
| Jerome D. Jabbour | President | Buy | $10K | 2019-06-12 |
| Adam K. Stern | Director | Buy | $12K | 2019-06-10 |
| Adam K. Stern | Director | Buy | $18K | 2019-06-07 |